{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:40:51Z","timestamp":1775634051303,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[1993,5,1]],"date-time":"1993-05-01T00:00:00Z","timestamp":736214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporosis Int"],"published-print":{"date-parts":[[1993,5]]},"DOI":"10.1007\/bf01623004","type":"journal-article","created":{"date-parts":[[2005,4,30]],"date-time":"2005-04-30T13:40:08Z","timestamp":1114868408000},"page":"21-27","source":"Crossref","is-referenced-by-count":48,"title":["Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin"],"prefix":"10.1007","volume":"3","author":[{"given":"S.","family":"Adami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Baroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Broggini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Carratelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gnessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Laurenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Norbiato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ortolani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ricerca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Romanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Subrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198606263142605","volume":"314","author":"BL Riggs","year":"1986","unstructured":"Riggs BL, Melton LJ. Involutional osteoporosis. N Engl J Med 1986;314:1676\u201386.","journal-title":"N Engl J Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02406145","volume":"36","author":"AM Parfitt","year":"1984","unstructured":"Parfitt AM. Age-related structural changes in trabecular and cortical bone: cellular mechanisms and biochemical consequences. Calcif Tissue Int 1984;36:123\u20138.","journal-title":"Calcif Tissue Int"},{"key":"CR3","unstructured":"Riggs BL. Toward optimal therapy of established osteoporosis: evidence that antiresorptive and formation stimulating regimens reduce vertebral fractures by independent mechanisms. In: Proceedings of the fourth international symposium on osteoporosis, Hong Kong, 1993:S30."},{"key":"CR4","unstructured":"Parfitt AM. Pathophysiology of bone fragility. In: Proceedings of the fourth international symposium on osteoporosis. Hong Kong, 1993:S43."},{"key":"CR5","first-page":"290","volume":"76","author":"R Lindsay","year":"1990","unstructured":"Lindsay R, Tohme JF. Estrogen treatment of patients with established osteoporosis. Obstet Gynecol 1990;76:290\u20135.","journal-title":"Obstet Gynecol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1471-0528.1992.tb13732.x","volume":"99","author":"PJ Ryan","year":"1992","unstructured":"Ryan PJ, Harrison R, Blake GM, Fogelman I. Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis. Br J Obstet Gynaecol 1992;99:325\u20138.","journal-title":"Br J Obstet Gynaecol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJM199208273270908","volume":"327","author":"BL Riggs","year":"1992","unstructured":"Riggs BL, Melton LJ. The prevention and treatment of osteoporosis. N Engl J Med 1992;327:620\u20137.","journal-title":"N Engl J Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00002512-199101050-00007","volume":"1","author":"SP Clissold","year":"1991","unstructured":"Clissold SP, Fitton A, Chrisp A. Intranasal salmon calcitonin: a review of its pharmacological properties and potential utility in metabolism bone disorders associated with aging. Drugs Aging 1991;1:405\u201323.","journal-title":"Drugs Aging"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI115539","volume":"88","author":"M Sato","year":"1991","unstructured":"Sato M, Grasser W, Endo N, et al. Bisphosphonate action: alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 1991;88:2095\u2013105.","journal-title":"J Clin Invest"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jbmr.5650060405","volume":"6","author":"JG Seedor","year":"1991","unstructured":"Seedor JG, Quartuccio H, Thompson DD. The bisphosphonate alendronate inhibits bone loss due to ovariectomy in rats. J Bone Miner Res 1991;6:339\u201346.","journal-title":"J Bone Miner Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jbmr.5650070812","volume":"7","author":"DD Thompson","year":"1992","unstructured":"Thompson DD, Seedor JG, Quartuccio H, Solomon H, Fioravanti C, Davidson J, et al. The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons. J Bone Miner Res 1992;7:951\u201360.","journal-title":"J Bone Miner Res"},{"key":"CR12","doi-asserted-by":"crossref","unstructured":"Seedor JG, Balena R, Masarachia P, Rodan GA. Comparison of the therapeutic potencies of two bisphosphonates. Bone 1992;13:S116.","DOI":"10.1016\/8756-3282(92)90573-F"},{"key":"CR13","unstructured":"Toolan BC, Shea M, Myers ER, et al. The effect of long term alendronate on vertebral strength in ovariectomized baboons and rats. J Bone Miner Res 1991;6(Suppl 1):S248."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/jbmr.5650071207","volume":"7","author":"BC Toolan","year":"1992","unstructured":"Toolan BC, Shea M, Myers ER, Borchers RE, Seedor JG, Quartuccio H, et al. Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats. J Bone Miner Res 1992;7:1399\u2013406.","journal-title":"J Bone Miner Res"},{"issue":"Suppl 3","key":"CR15","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/BF01623005","volume":"3","author":"DM Black","year":"1993","unstructured":"Black DM, Reiss TR, Karpf DB, Cummings SR. Fracture intervention trial: design and interim recruitment results. Osteoporosis Int 1993;3 (Suppl 3):S29\u201339.","journal-title":"Osteoporosis Int"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0140-6736(93)92555-8","volume":"341","author":"SR Cummings","year":"1993","unstructured":"Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993;341:72\u20134.","journal-title":"Lancet"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/8756-3282(91)90023-C","volume":"12","author":"C Cooper","year":"1991","unstructured":"Cooper C, Wickham C, Walsh K. Appendicular skeletal status and hip fracture in the elderly: 14-year prospective data. Bone 1991;12:361\u20134.","journal-title":"Bone"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1172\/JCI113523","volume":"81","author":"SL Hui","year":"1988","unstructured":"Hui SL, Slemenda CW, Johnston CC. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 1988;81:1804\u20139.","journal-title":"J Clin Invest"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-114-11-919","volume":"114","author":"PD Ross","year":"1991","unstructured":"Ross PD, Davis JW, Epstein RS, Wasnich RD. Preexisting fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991;114:919\u201323.","journal-title":"Ann Intern Med"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0140-6736(90)91801-G","volume":"335","author":"JC Stevenson","year":"1990","unstructured":"Stevenson JC, Cust MP, Gangar KF, Hillard TC, Lees B, Whitehead MI. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet 1990;335:265\u20139.","journal-title":"Lancet"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF02555748","volume":"38","author":"R Schenk","year":"1986","unstructured":"Schenk R, Eggli P, Fleisch H, Rosini S. Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat. Calcif Tissue Int 1986;38:342\u20139.","journal-title":"Calcif Tissue Int"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(84)92272-4","volume":"11","author":"BF Boyce","year":"1984","unstructured":"Boyce BF, Smith R, Fogelman I, Johnston E, Ralston S, Boyle IT. Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease. Lancet 1984;11:821\u20134.","journal-title":"Lancet"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","volume":"323","author":"NB Watts","year":"1990","unstructured":"Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990;323:73\u20139.","journal-title":"N Engl J Med"},{"key":"CR24","first-page":"183","volume":"5","author":"T Storm","year":"1990","unstructured":"Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH. Effect of intermittent cyclical etidronate on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990:5:183\u201392.","journal-title":"N Engl J Med"},{"key":"CR25","first-page":"227","volume":"143","author":"HM Frost","year":"1979","unstructured":"Frost HM. Treatment of osteoporosis by manipulation of coherent bone cell populations. Clin Orthop 1979;143:227\u201344.","journal-title":"Clin Orthop"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0169-6009(89)90095-0","volume":"5","author":"R Valkema","year":"1989","unstructured":"Valkema R, Vismans FJFE, Papapoulos SE, Powels EKJ, Bijvoet OLM. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD. Bone Miner 1989;5:183\u201392.","journal-title":"Bone Miner"},{"key":"CR27","unstructured":"Santora AC, Bell NH, Chesnut CH, Ensrud K, Genant HK, Grimm R, et al. Oral alendronate treatment of bone loss in postmenopausal osteopenic women. [abstract] J Bone Miner Res 1993:8(Suppl 1):S131."},{"key":"CR28","unstructured":"McClung MR, Yates AJ. Alendronate prevents or reverses bone loss at the spine and hip in recently menopausal women. [abstract] J Bone Miner Res 1993;8(Suppl 1):S141."},{"key":"CR29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF02556148","volume":"48","author":"G Thamsborg","year":"1991","unstructured":"Thamsborg G, Storm TL, Sykulski R, Brinch E, Nielsen HK, S\u00f8rensen OH. Effect of different doses of nasal salmon calcitonin on bone mass. Calcif Tissue Int 1991;48:302\u20137.","journal-title":"Calcif Tissue Int"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bmj.305.6853.556","volume":"305","author":"K Overgaard","year":"1992","unstructured":"Overgaard K, Hansen MA, Jensen SB, Christiansen C. Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ 1992;305:556\u201361.","journal-title":"BMJ"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2265.1989.tb00443.x","volume":"30","author":"K Overgaard","year":"1989","unstructured":"Overgaard K, Riis BJ, Christiansen C, P\u00f8denphant J, Johansen JS. Nasal calcitonin for treatment of established osteoporosis. Clin Endocrinol 1989;30:435\u201342.","journal-title":"Clin Endocrinol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(90)90089-V","volume":"89","author":"K Overgaard","year":"1990","unstructured":"Overgaard K, Hansen MS, Heiss Nielsen VA, Riis BJ, Christiansen C. Discontinuous calcitonin treatment of established osteoporosis: effects of withdrawal of treatment. Am J Med 1990;89:1\u20136.","journal-title":"Am J Med"},{"key":"CR33","unstructured":"Meunier PJ, Gozzo I, Chaumet-Riffaud PD, Delmas PD, Guignard M, Chapuy MC, Duboeuf F. Dose-effect on bone density and parathyroid function of intranasal salmon calcitonin when administered without calcium in postmenopausal women. [abstract]. J Bone Miner Res 1992;7(Suppl 1):abst.950."}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01623004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01623004\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01623004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T12:34:20Z","timestamp":1556886860000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01623004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,5]]},"references-count":33,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[1993,5]]}},"alternative-id":["BF01623004"],"URL":"https:\/\/doi.org\/10.1007\/bf01623004","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,5]]}}}